Search Results 1521-1530 of 10347 for ACTH Stimulation Test

  1. A Study Of Selpercatinib Following Definitive Locoregional Treatment In Participants With Non-small Cell Lung Cancer - Mayo Clinic

    ... Test or locally from a laboratory with ... [Any pregnancy testing subsequent to this initial test ... stimulating hormone > 40 mIU/mL; or; A woman 55 or ...

  2. A Study Of AG-946 In Participants With Anemia Due To Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

    Up to 2 prior therapies including erythropoiesis-stimulating ... stimulating factor [G-CSF]) and/or luspatercept ... Positive test for hepatitis C virus (HCV) ...

  3. Hematology - Clinical trials

    Germline and somatic variants are changes in genes found using cancer genomic tests. Cancer genetic/genomic testing is a series of tests that find specific ...

  4. Publications - Mayo Clinic

    A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome. JAMA ... Cardiac Sarcoidosis Mimickers: Genetic Testing in Undifferentiated ...

  5. First In Human (FIH) Study Of REGN5459 In Patients With Relapsed Or Refractory Multiple Myeloma (MM) - Mayo Clinic

    Tests & Procedures A-Z · Drugs & Supplements A-Z ... Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.

  6. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to delineate the neural mechanisms of VNS-REHAB (Vagus Nerve Stimulation paired with task-specific upper limb rehabilitation).

  7. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to delineate the neural mechanisms of VNS-REHAB (Vagus Nerve Stimulation paired with task-specific upper limb rehabilitation).

  8. Medtronic Study With Personalized Closed Loop - Mayo Clinic

    Women of child-bearing potential who have a positive pregnancy test at Visit 1 or plan to become pregnant during the course of the study. Females who are ...

  9. A Phase 1 Study Evaluating Intratumoral Administration Of JNJ-1761981 ER In Solid Tumors - Mayo Clinic

    ... test at screening and within 72 hours of the first dose of study treatment and must agree to further serum or urine pregnancy tests during the study. A ...

  10. The ELiSA Study - Evaluation Of Lixivaptan In Subjects With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    ... test results. A single repeat assessment is ... stimulating hormone [FSH] ≥ 40 mIU/mL ... Subjects with a history of testing positive for hepatitis ...